Wolfe starts AbbVie at Outperform, says valuation an attractive entry point
Wolfe Research initiated coverage of AbbVie (ABBV) with an Outperform rating and $205 price target The firm noted that AbbVie sounded ...
Irish Independent on MSN40m
Profits drop at Botox plant in Westport as revenues down by 4pc
Pre-tax profits at AbbVie’s global production facility for Botox, in Westport, last year declined by 27pc to $1.1bn (€1.04bn). New accounts filed by Allergan Pharmaceuticals Ireland UC show that the ...